Humoral Response to SARS-CoV-2 Vaccine of a Patient Receiving Methotrexate Treatment and Implications for the Need of Monitoring

We report a case of monitoring the antibody response to the BioNTech–Pfizer vaccine of a 50-year-old female diagnosed with rheumatoid arthritis undergoing treatment with methotrexate (MTX). Antibody levels were measured 21 days after dose 1 (i.e., on the day of dose 2) and then 8, 14 and 30 days aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Lukaszuk, Krzysztof, Woclawek-Potocka, Izabela, Jakiel, Grzegorz, Malinowska, Paulina, Wdowiak, Artur, Rozanska, Karolina, Rabalski, Lukasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541181/
https://www.ncbi.nlm.nih.gov/pubmed/34696259
http://dx.doi.org/10.3390/vaccines9101151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541181/
https://www.ncbi.nlm.nih.gov/pubmed/34696259
http://dx.doi.org/10.3390/vaccines9101151

Ejemplares similares